Table 1.
Source, MICs (mg/L), and resistance genes
| Strain | Species WGS | Country | Isolate source | Aztreonam | Ceftazidime | Ciptrofloxacin | Colistin |
|---|---|---|---|---|---|---|---|
| 16-551634 | R. pickettii | The Netherlands | Blood culture | 128 | 16 | 0.12 | > 16 |
| 16-551636 | R. pickettii | The Netherlands | Blood culture | 256 | 8 | 0.12 | > 16 |
| 16-543514 | R. pickettii | The Netherlands | Blood culture | 256 | 16 | 0.06 | > 16 |
| 16-551632 | R. pickettii | The Netherlands | Blood culture | 256 | 8 | 0.12 | > 16 |
| 16-551637 | R. pickettii | The Netherlands | Blood culture | > 256 | 8 | 0.06 | > 16 |
| 16-543504 | R. pickettii | The Netherlands | Blood culture | > 256 | 32 | 0.12 | > 16 |
| 16-551631 | R. pickettii | The Netherlands | Furunkulosis | > 256 | 32 | 0.25 | > 16 |
| 16-551635 | R. pickettii | The Netherlands | Spondylodicitis | > 256 | 32 | 0.25 | > 16 |
| 16-535633 | R. mannitolilytica | Spain | CF | > 256 | 64 | > 32 | > 16 |
| 16-535634 | R. mannitolilytica | Spain | CF | > 256 | 256 | 4 | > 16 |
| 16-535635 | R. mannitolilytica | Spain | CF | > 256 | 64 | 0.25 | > 16 |
| 16-545260 | R. mannitolilytica | USA | CF | > 256 | 32 | > 32 | > 16 |
| 16-545261 | R. mannitolilytica | USA | CF | > 256 | 16 | 32 | > 16 |
| 16-535632 | R. mannitolilytica | Spain | CF | 256 | 16 | 32 | > 16 |
| 16-535638 | R. mannitolilytica | Spain | CF | > 256 | 16 | 0.12 | > 16 |
| 16-543498 | R. mannitolilytica | The Netherlands | Blood culture | > 256 | 32 | 0.12 | > 16 |
| 16-551633 | R. insidiosa | The Netherlands | Blood culture | > 256 | 16 | 0.12 | > 16 |
| 16-535637 | R. new spp. | Spain | CF | > 256 | 16 | 0.12 | > 16 |
| Strain | Co-trimoxazole | Imipenem | Meropenem | Tobramycin | Resistance genes | Group1 | |
|---|---|---|---|---|---|---|---|
| 16-551634 | <=0.06 | <=0.12 | 0.5 | 64 | blaOXA-22 family, blaOXA-60 family | E2 | |
| 16-551636 | <=0.06 | 16 | 32 | 64 | blaOXA-22 family, blaOXA-60 family | E2 | |
| 16-543514 | <=0.06 | 8 | 64 | 64 | blaOXA-22 family, blaOXA-60 family | E2 | |
| 16-551632 | <=0.06 | 8 | 16 | 16 | blaOXA-22 family, blaOXA-60 family | E2 | |
| 16-551637 | <=0.06 | 8 | 32 | 16 | blaOXA-22 family, blaOXA-60 family | E2 | |
| 16-543504 | <=0.06 | 8 | > 64 | 2 | blaOXA-22 family, blaOXA-60 family | E1 | |
| 16-551631 | <=0.06 | 2 | 8 | 16 | blaOXA-22 family, blaOXA-60 family | E1 | |
| 16-551635 | <=0.06 | 8 | 8 | 16 | blaOXA-22 family, blaOXA-60 family | E1 | |
| 16-535633 | 8 | 64 | > 64 | > 128 | blaOXA-22 family, blaOXA-60 family | D2 | |
| 16-535634 | 8 | 128 | > 64 | 128 | blaOXA-22 family, blaOXA-60 family | D2 | |
| 16-535635 | 0.12 | 32 | 64 | 128 | blaOXA-22 family, blaOXA-60 family | D2 | |
| 16-545260 | 32 | 16 | > 64 | > 128 | blaOXA-22 family, blaOXA-60 family, aadA2, ant(2'')-Ia, aph(6)-Id, cmlA1, strA, sul1 | D2 | |
| 16-545261 | 2 | 4 | 64 | 128 | blaOXA-22 family, blaOXA-60 family, aadA2, ant(2'')-Ia, aph(6)-Id, cmlA1, strA, sul1 | D2 | |
| 16-535632 | 1 | 32 | > 64 | 128 | blaOXA-22 family, blaOXA-60 family | D2 | |
| 16-535638 | 0.12 | 32 | > 64 | 32 | blaOXA-22 family, blaOXA-60 family | D1 | |
| 16-543498 | 0.12 | 64 | > 64 | 64 | blaOXA-22 family, blaOXA-60 family | D1 | |
| 16-551633 | <=0.06 | 16 | 32 | 64 | blaOXA-22 family, blaOXA-60 family | G | |
| 16-535637 | 0.25 | 8 | 8 | 32 | blaOXA-22 family, blaOXA-60 family | F |
1Groups defined on basis of the ANIb (Fig. 2 and supplementary Fig. 1)